1. Targeted Macrophage Modulation as a Disease-Modifying Approach in Canine Osteoarthritis: The Efficacy of EF-M2 (ImmutalonTM) in a Double-Blind Placebo-Controlled Study

    Pokushalov, E., Kudlay, D., Revkov, N., Shcherbakova, A., Johnson, M. & Miller, R., 22 Sept 2025, In: Veterinary Sciences. 12, 9, 919.

    Research output: Contribution to journalArticlepeer-review

  2. Optimizing Weight Loss with Artificial Intelligence: A Randomized Controlled Trial of Dietary-Supplement Prescriptions in Adults with Overweight and Obesity

    Pokushalov, E., Garcia, C., Ponomarenko, A., Samoilova, I., Smith, J., Johnson, M., Pak, I., Shrainer, E., Kudlay, D., Romanova, A. & Miller, R., Oct 2025, In: Clinical Nutrition ESPEN. 69, p. 75-86 12 p.

    Research output: Contribution to journalArticlepeer-review

  3. Isopimaric Acid Derivatives as Potential Dual PPARα/γ Agonists in the Treatment of Metabolic Syndrome

    Blokhin, M. E., Borisov, S. A., Gromova, M. A., Meshkova, Y. V., Zhukova, N. A., Nikonova, S. V., Zhurakovsky, I. P., Luzina, O. A., Khvostov, M. V., Kudlay, D. A. & Salakhutdinov, N. F., 5 Sept 2025, In: Scientia Pharmaceutica. 93, 3, 44.

    Research output: Contribution to journalArticlepeer-review

  4. Adjunct EF-M2 therapy improves clinical activity, steroid-sparing, and macrophage-linked biomarkers in feline chronic enteropathy: A randomized, double-blind, and placebo-controlled trial

    Pokushalov, E., Garcia, C., Smith, J., Kudlay, D., Revkov, N., Shcherbakova, A., Johnson, M. & Miller, R., Dec 2025, In: Veterinary World. 18, 12, p. 3914-3928 15 p.

    Research output: Contribution to journalArticlepeer-review

Previous 1 2 Next

ID: 65414320